H.B. Fuller Closes $850M 7.625% Notes Due 2034, Retires $917M Bridge Loan
FUL is trading near its 52-week low of $46.7 (8.5% above the low).
Summary
H.B. Fuller issued $850 million of 7.625% notes due 2034 to fund its Advanced Medical Solutions acquisition and terminated the $917 million bridge loan backing the deal. Half the notes must be redeemed at par if the acquisition does not close by June 25, 2027.
Key Events · Financing and Capital Events · FUL
-
Notes Offering Closes at $850M
On October 21, 2026, H.B. Fuller completed the issue and sale of $850,000,000 aggregate principal amount of 7.625% Notes due 2034, below the $950 million offering announced on October 6.
-
Bridge Loan Terminated
The $917,000,000 Unsecured Bridge Credit Agreement dated June 25, 2026 was terminated with no loans outstanding, no prepayment premium, and all accrued fees paid.
-
Acquisition-Linked Redemption Deadline
If the AMS acquisition is not consummated by June 25, 2027, extendable to no later than October 21, 2027, $450,000,000 of the notes must be redeemed at 100% of the initial issue price plus accrued interest.
-
Coupon and Terms
The notes carry 7.625% per annum, with semi-annual interest beginning April 15, 2027; they are senior unsecured, mature October 15, 2034, and include a 101% change-of-control repurchase right.
Analysis · FUL · Industrial Applications And Services
The debt financing for H.B. Fuller's pending Advanced Medical Solutions acquisition is now in place: $850 million of 7.625% senior unsecured notes due 2034 were issued, and the $917 million bridge credit facility standing behind the deal was terminated. For an investment-grade-style industrial, that coupon is expensive, and the structure carries a hard deadline — $450 million of the notes must be redeemed at par if the AMS acquisition is not completed by June 25, 2027 (extendable to no later than October 21, 2027). Final size came in $100 million below the $950 million offering announced on October 6, which modestly reduces leverage but also trims the cash cushion for the acquisition. No equity dilution here — this is debt, and the bridge termination removes a contingent financing overhang.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 29.4% of the 1560 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FUL was trading at $50.66 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $46.70 to $68.63. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.